ECO Animal Health Group's subsidiary ECO Animal Health said Tuesday it had signed a second global exclusive licensing deal with the Poultry Diagnostic & Research Center, College of Veterinary Medicine at the University of Georgia.
The deal would allow the company to 'further develop, register and commercialise a live attenuated Mycoplasma synoviae vaccine for poultry developed by University of Georgia,' the company said. University researchers had concluded preliminary proof of concept efficacy and safety studies with this vaccine.
'Mycoplasma synoviae is a bacterium that affects predominately commercial layers and breeding birds worldwide resulting in a 5 to 10 per cent loss in egg production and lower egg quality in affected flocks,' said Peter Lawrence, Non-Executive Chairman of ECO Animal Health Group.
At 10:48am: (LON:EAH) Eco Animal Health Group PLC share price was 0p at 465p